Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17162603rdf:typepubmed:Citationlld:pubmed
pubmed-article:17162603lifeskim:mentionsumls-concept:C0042170lld:lifeskim
pubmed-article:17162603lifeskim:mentionsumls-concept:C0021079lld:lifeskim
pubmed-article:17162603lifeskim:mentionsumls-concept:C0205174lld:lifeskim
pubmed-article:17162603lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:17162603pubmed:issue6lld:pubmed
pubmed-article:17162603pubmed:dateCreated2006-12-12lld:pubmed
pubmed-article:17162603pubmed:abstractTextTo describe the role of triple agent immunosuppression in severe recalcitrant cases of Vogt-Koyanagi-Harada syndrome.lld:pubmed
pubmed-article:17162603pubmed:languageenglld:pubmed
pubmed-article:17162603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:citationSubsetIMlld:pubmed
pubmed-article:17162603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17162603pubmed:statusMEDLINElld:pubmed
pubmed-article:17162603pubmed:monthDeclld:pubmed
pubmed-article:17162603pubmed:issn0927-3948lld:pubmed
pubmed-article:17162603pubmed:authorpubmed-author:BiswasJyotirm...lld:pubmed
pubmed-article:17162603pubmed:authorpubmed-author:AgarwalMamtaMlld:pubmed
pubmed-article:17162603pubmed:authorpubmed-author:GaneshSudha...lld:pubmed
pubmed-article:17162603pubmed:issnTypePrintlld:pubmed
pubmed-article:17162603pubmed:volume14lld:pubmed
pubmed-article:17162603pubmed:ownerNLMlld:pubmed
pubmed-article:17162603pubmed:authorsCompleteYlld:pubmed
pubmed-article:17162603pubmed:pagination333-9lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:meshHeadingpubmed-meshheading:17162603...lld:pubmed
pubmed-article:17162603pubmed:year2006lld:pubmed
pubmed-article:17162603pubmed:articleTitleTriple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.lld:pubmed
pubmed-article:17162603pubmed:affiliationMedical Research Foundation, Sankara Nethralaya, Chennai, India.lld:pubmed
pubmed-article:17162603pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17162603pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:17162603pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed